ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,960.51
      -1.01%
      US Tech 100
      16,570.40
      -2.16%
      Dow Jones
      37,952.18
      0.47%
      Brent Oil
      86.69
      0.32%
      Bitcoin
      64,203.01
      1.08%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Amgen Inc (AMGN)

      7. Amgen Inc (AMGN) News

      AMGN Amgen Inc

      268.89
      6.14 (2.34%)
      Last Updated: 15:35:58
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Amgen Inc AMGN NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      6.14 2.34% 268.89 15:35:58
      Open Price Low Price High Price Close Price Prev Close
      264.63 262.01 269.21 262.75
      more quote information »

      Recent News

      Date Time Source Heading
      4/16/202417:26PRNUSAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
      3/09/202412:20PRNUSAMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD..
      3/08/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:00PRNUSAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
      2/29/202416:00PRNUSAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE..
      2/26/202409:00PRNUSAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN..
      2/19/202416:00PRNUSAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
      2/14/202416:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/12/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:00PRNUSAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE..
      2/07/202405:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
      2/06/202417:05IHMARKETNEWSU.S. Stocks Finish Choppy Trading Day Modestly Higher
      2/06/202416:20EDGAR2Form 8-K - Current report
      2/06/202416:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
      2/06/202406:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
      2/02/202416:25IHMARKETNEWSU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon..
      2/01/202416:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR..
      1/29/202405:00PRNCAdeCODE genetics: A sequence variant that increases risk of..
      1/17/202406:33IHMARKETNEWSWall Street Highlights: Tesla Cuts Prices in Germany,..
      1/10/202410:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
      1/10/202408:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
      1/10/202408:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
      1/03/202416:00PRNUSAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE..
      1/02/202411:42DJNAmgen On Pace for Record High Close -- Data Talk
      12/26/202309:00PRNUSAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS®..
      12/19/202320:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
      12/14/202309:53DJNAmgen Names James Bradner Chief Scientific Officer
      12/14/202309:16EDGAR2Form 8-K - Current report
      12/14/202309:00PRNUSAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE..
      12/14/202305:00PRNUSAMGEN TO SPONSOR THE IRISH OPEN
      12/13/202316:40DJNAmgen Gets FDA Priority Review For Lung Cancer Treatment
      12/13/202316:00PRNUSFDA Grants Priority Review to Amgen's Tarlatamab Application..
      12/13/202306:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
      12/12/202316:41DJNAmgen Raises Dividend 5.6% To $2.25 A Share
      12/12/202316:00PRNUSAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO..
      12/08/202309:00PRNUSAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
      12/04/202319:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/04/202319:40EDGAR2Form 144 - Report of proposed sale of securities
      11/29/202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/22/202316:00PRNUSAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE
      11/13/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      AMGN
      Amgen
      Delayed Upgrade Clock